Homepage - Bayer Life Talks_Home & Family

Series OverviewSessionsSession 1Session 2Session 3ContactMenuSeries OverviewSessionsSession 1Session 2Session 3ContactREGISTERWelcome to Bayer Life TalksThe Bayer Life Talks series is designed as a platform for open and public discussion on how innovations in life sciences should play a role in modern economies, and the contribution they can make to overcoming societal challenges. The first of the sessions took place on 9 September and focused on gene editing, following the European Commission’s recent study on new genomic techniques. While the second session of 2021 took place 8 December and looked at the fault lines and opportunities in the relationship between policymakers, business, and the scientific community.If you are interested in learning more about the series, please contact us here.Watch the highlights video below, or scroll down to read in further detail about past and upcoming sessions.Latest Session - 16 March 2022 - OnlineForest Protection: Mitigating Climate Change, Fostering Biodiversity & Delivering on the Green Deal The third session of the Bayer Life Talks took place virtually on 16 March 2022 between 15:00 and 16:15 CET. Further details on the topic and key themes of the event can be found by clicking the button below.Read more about Session 3Previous SpeakersPaul Adamson,Chairman, Forum EuropeNicole Grobert,Chair,Group of Chief Scientific Advisors to the European CommissionMaria da Graça Carvalho,Member,European ParliamentMichael Vorländer,Head of Unit,Education and Research,German Permanent Representation to the EUDavid Mair,Head of Unit,Science Advice to Policy,EC Joint Research CentreDr Anna-Maija Mertens,Executive Director,Transparency International GermanyLidia Borrell-Damián,Secretary-General,Science EuropeStephan Schraff,Head,Public Affairs European Union,Bayer AGMonika Lessl,SVP,Head Corporata R&D and Social Innovation,Bayer AGJorrit Kiewik,Executive Director,Slow Food Youth NetworkJulian Kinderlerer,Emeritus Professor of Intellectual Property Law,Cape Town UniversityClaire Bury,Deputy Director-General,DG SANTE,European CommissionPreviousNextPrevious SessionsSession 1(9 September 2021)The Bio Revolution – What’s in it for Europe?The United Nations estimates that the global population will reach ten billion over the next 30 years. Therefore, demand on food supplies and healthcare is expected to intensify – problems already exacerbated over the past 12 months by the impact of Covid-19.The current pandemic has demonstrated the potential for new technologies to contribute to meeting such challenges. The virus’s genome was sequenced in a matter of weeks, while the mRNA vaccines that are now being rolled out across the world are also significant for future disease treatment. The speed of the scientific response is cause for optimism and indicative of a technological revolution – a ‘Bio Revolution’ – in the life sciences. Read more about Session 1Session 2(8 December 2021)The Science of Transparency: Delivering Quality of Life Improvements through Transparent Science & PolicymakingA trusted relationship between science, business, and policymaking is essential for the proper functioning of our democracies. Science and academia play a necessary role in policymaking, offering evidence-based research to guide the formulation and direction of the rules that govern. We are, however, living in a period of increased distrust in traditional institutions, with the organisations and experts that were once valued and relied upon, now subject to growing skepticism.In the context of the recent strengthening of transparency rules for those seeking to influence policymaking in Europe and following the public consultation on developing a fit for purpose European innovation ecosystem to boost innovation cohesion, this second session in the Bayer Life Talks will look at the fault lines and opportunities in the relationship between policymakers, business, and the scientific community. It will debate the role of business in funding academic and scientific research and what tools are available to ensure transparency and accountability in the process. What guard rails currently exist to ensure that evidence-based policymaking can thrive?Read more about Session 2Resource CentreClick here to view resources for Session 1 Click here to view resources for Session 2Event PartnersGet in touchFor more information on any aspect of the Bayer Life Talks series, please contact us using the details below:Joe NottEvent Executive | Forum EuropeTel:+44 (0) 2920 783 020Email: [email protected]Privacy Policy | Cookies PolicyManage Cookie ConsentTo provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.FunctionalFunctionalAlways activeThe technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.PreferencesPreferencesThe technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.StatisticsStatisticsThe technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.MarketingMarketingThe technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.Manage optionsManage servicesManage vendorsRead more about these purposesAcceptDenyView preferencesSave preferencesView preferences{title}{title}{title}Manage consent